MR. PABLO C REYES MD NPI 1891729786

NPI Information

  • NPI: 1891729786
  • Provider Name: MR. PABLO C REYES, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1400 N US HIGHWAY 441
    SUITE 924
    THE VILLAGES, FL
    ZIP 32159
  • Phone: (352) 633-8319

Map and Directions

Get Directions

NPI Details

MR. Pablo C Reyes, MD is a medical oncology internal medicine in The Villages, FL with 34 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. MR. Pablo C Reyes, MD NPI is 1891729786. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1400 N US HIGHWAY 441
SUITE 924
THE VILLAGES, FL
ZIP 32159-975
Phone: (352) 633-8319
Fax: (352) 633-8434

The NPI 1891729786 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Blood test, clotting time (HCPCS:85610)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Protein measurement, serum (HCPCS:84165)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Magnesium level (HCPCS:83735)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Uric acid level, blood (HCPCS:84550)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Automated urinalysis test (HCPCS:81003)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Urinalysis, manual test (HCPCS:81002)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Red blood count automated, with additional calculations (HCPCS:85046)

The enumeration date for this NPI number is 7/10/2006 and was last updated on 8/19/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineME80262FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME80262FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
135656OTHERFLORIDABCBS
2262620900MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.